AT1-IR-beta association: A new mechanism for the inhibition of insulin receptor function in breast cancer

Lakshmi Pulakat, Ravindra Bharat Kolhe, Nara Gavini

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Epidemiological evidence show that increased mortality in breast cancer is linked to hypertension and insulin resistance. Because Angiotensin II (Ang II), a hormone implicated in hypertension and insulin resistance, is a normal mitogen for breast tissue and elevated expression of the Ang II receptor AT1 is seen in breast cancer, we analyzed the effects of Ang II exposure on the functions of IR in human breast cancer cell line MCF-7. Exposure of MCF-7 to Ang II for 2 hours a) significantly reduced 125I-insulin binding to IR, and b) induced co-immuno-precipitation of the AT1 with IR-beta subunit. These Ang II-mediated effects on IR were inhibited by the AT1 antagonist losartan, and were not observed when exposure time was below 1-hour. These observations suggest extended exposure to Ang II have detrimental effects on insulin binding to IR that were not discovered in the previous studies where Ang II-exposure of insulin responsive cells was performed for periods less than one hour. In addition, they suggest a novel mechanism that involves AT1-IR-beta association for the inhibition of insulin binding to IR in response to extended exposure (2-hours) of breast cancer cells to elevated levels of Ang II (as seen in hypertensive patients), and provides a molecular link for the inhibition of normal IR signaling by Ang II in breast cancer.

Original languageEnglish (US)
Pages (from-to)24-34
Number of pages11
JournalAmerican Journal of Biochemistry and Biotechnology
Volume4
Issue number1
DOIs
StatePublished - Jan 1 2008
Externally publishedYes

Fingerprint

Insulin Receptor
Angiotensin II
Breast Neoplasms
Insulin
Insulin Resistance
Hypertension
Cells
Angiotensin Receptors
Losartan
Mitogens
Breast
Hormones
Cell Line
Tissue
Mortality

Keywords

  • AT1 receptor
  • Angiotensin II
  • Insulin
  • Insulin receptor
  • Receptor-receptor interaction

ASJC Scopus subject areas

  • Biotechnology
  • Biochemistry

Cite this

AT1-IR-beta association : A new mechanism for the inhibition of insulin receptor function in breast cancer. / Pulakat, Lakshmi; Kolhe, Ravindra Bharat; Gavini, Nara.

In: American Journal of Biochemistry and Biotechnology, Vol. 4, No. 1, 01.01.2008, p. 24-34.

Research output: Contribution to journalArticle

@article{52d4222a1cb44cd095c43e1929fe9512,
title = "AT1-IR-beta association: A new mechanism for the inhibition of insulin receptor function in breast cancer",
abstract = "Epidemiological evidence show that increased mortality in breast cancer is linked to hypertension and insulin resistance. Because Angiotensin II (Ang II), a hormone implicated in hypertension and insulin resistance, is a normal mitogen for breast tissue and elevated expression of the Ang II receptor AT1 is seen in breast cancer, we analyzed the effects of Ang II exposure on the functions of IR in human breast cancer cell line MCF-7. Exposure of MCF-7 to Ang II for 2 hours a) significantly reduced 125I-insulin binding to IR, and b) induced co-immuno-precipitation of the AT1 with IR-beta subunit. These Ang II-mediated effects on IR were inhibited by the AT1 antagonist losartan, and were not observed when exposure time was below 1-hour. These observations suggest extended exposure to Ang II have detrimental effects on insulin binding to IR that were not discovered in the previous studies where Ang II-exposure of insulin responsive cells was performed for periods less than one hour. In addition, they suggest a novel mechanism that involves AT1-IR-beta association for the inhibition of insulin binding to IR in response to extended exposure (2-hours) of breast cancer cells to elevated levels of Ang II (as seen in hypertensive patients), and provides a molecular link for the inhibition of normal IR signaling by Ang II in breast cancer.",
keywords = "AT1 receptor, Angiotensin II, Insulin, Insulin receptor, Receptor-receptor interaction",
author = "Lakshmi Pulakat and Kolhe, {Ravindra Bharat} and Nara Gavini",
year = "2008",
month = "1",
day = "1",
doi = "10.3844/ajbbsp.2008.24.34",
language = "English (US)",
volume = "4",
pages = "24--34",
journal = "American Journal of Biochemistry and Biotechnology",
issn = "1553-3468",
publisher = "Science Publications",
number = "1",

}

TY - JOUR

T1 - AT1-IR-beta association

T2 - A new mechanism for the inhibition of insulin receptor function in breast cancer

AU - Pulakat, Lakshmi

AU - Kolhe, Ravindra Bharat

AU - Gavini, Nara

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Epidemiological evidence show that increased mortality in breast cancer is linked to hypertension and insulin resistance. Because Angiotensin II (Ang II), a hormone implicated in hypertension and insulin resistance, is a normal mitogen for breast tissue and elevated expression of the Ang II receptor AT1 is seen in breast cancer, we analyzed the effects of Ang II exposure on the functions of IR in human breast cancer cell line MCF-7. Exposure of MCF-7 to Ang II for 2 hours a) significantly reduced 125I-insulin binding to IR, and b) induced co-immuno-precipitation of the AT1 with IR-beta subunit. These Ang II-mediated effects on IR were inhibited by the AT1 antagonist losartan, and were not observed when exposure time was below 1-hour. These observations suggest extended exposure to Ang II have detrimental effects on insulin binding to IR that were not discovered in the previous studies where Ang II-exposure of insulin responsive cells was performed for periods less than one hour. In addition, they suggest a novel mechanism that involves AT1-IR-beta association for the inhibition of insulin binding to IR in response to extended exposure (2-hours) of breast cancer cells to elevated levels of Ang II (as seen in hypertensive patients), and provides a molecular link for the inhibition of normal IR signaling by Ang II in breast cancer.

AB - Epidemiological evidence show that increased mortality in breast cancer is linked to hypertension and insulin resistance. Because Angiotensin II (Ang II), a hormone implicated in hypertension and insulin resistance, is a normal mitogen for breast tissue and elevated expression of the Ang II receptor AT1 is seen in breast cancer, we analyzed the effects of Ang II exposure on the functions of IR in human breast cancer cell line MCF-7. Exposure of MCF-7 to Ang II for 2 hours a) significantly reduced 125I-insulin binding to IR, and b) induced co-immuno-precipitation of the AT1 with IR-beta subunit. These Ang II-mediated effects on IR were inhibited by the AT1 antagonist losartan, and were not observed when exposure time was below 1-hour. These observations suggest extended exposure to Ang II have detrimental effects on insulin binding to IR that were not discovered in the previous studies where Ang II-exposure of insulin responsive cells was performed for periods less than one hour. In addition, they suggest a novel mechanism that involves AT1-IR-beta association for the inhibition of insulin binding to IR in response to extended exposure (2-hours) of breast cancer cells to elevated levels of Ang II (as seen in hypertensive patients), and provides a molecular link for the inhibition of normal IR signaling by Ang II in breast cancer.

KW - AT1 receptor

KW - Angiotensin II

KW - Insulin

KW - Insulin receptor

KW - Receptor-receptor interaction

UR - http://www.scopus.com/inward/record.url?scp=38349076527&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38349076527&partnerID=8YFLogxK

U2 - 10.3844/ajbbsp.2008.24.34

DO - 10.3844/ajbbsp.2008.24.34

M3 - Article

AN - SCOPUS:38349076527

VL - 4

SP - 24

EP - 34

JO - American Journal of Biochemistry and Biotechnology

JF - American Journal of Biochemistry and Biotechnology

SN - 1553-3468

IS - 1

ER -